Cite
APA Citation
Denisov, L., Shesternya, P., Plaksina, T., Kropotina, T., Soroka, N., Kunder, E., Lutskii, A., Eremeeva, A., Dokukina, E., Chernyaeva, E., Ivanov, R., & Mazurov, V. (n.d.). sAT0267 Efficacy and safety of bcd-055, proposed infliximab biosimilar, compared to infliximab: 54-week results from asart-2 phase 3 clinical study. Annals of the rheumatic diseases, 77, 997. http://access.bl.uk/ark:/81055/vdc_100144712201.0x00004e